Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -98.29% is 50% above its 5-year average of -198.18%, near the high end of its 5-year range (-529.77%–-49.88%).
As of the fiscal period ended Tuesday, June 30, 2026. 68.70% above its 12-month average of -314.03%.
Reported quarterly return on assets; no daily interpolation. Q4 FY2026 (2026-06-30): -51.13%.
RETURN ON ASSETS (ROA)
-98.29%
RETURN ON ASSETS (ROA) AVG TTM
-314.03%
RETURN ON ASSETS (ROA) AVG 3Y
-259.71%
RETURN ON ASSETS (ROA) AVG 5Y
-198.18%
RETURN ON ASSETS (ROA) AVG 10Y
-146.31%
RETURN ON ASSETS (ROA) AVG 15Y
-89.07%
RETURN ON ASSETS (ROA) AVG 20Y
-53.69%
CURRENT VS TTM AVG
+68.70%
CURRENT VS 3Y AVG
+62.15%
CURRENT VS 5Y AVG
+50.40%
CURRENT VS 10Y AVG
+32.82%
CURRENT VS 15Y AVG
-10.36%
CURRENT VS 20Y AVG
-83.08%
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-204.87%
vs the sector median at left
Palatin Technologies, Inc.
Market Cap
$17.14M
Return on Assets (ROA)
-98.29%
TTM Avg
-314.03%
3Y Avg
-259.71%
5Y Avg
-198.18%
Market Cap
$17.11M
Return on Assets (ROA)
-49.72%
TTM Avg
-28.29%
3Y Avg
-39.08%
5Y Avg
-40.04%
Market Cap
$16.75M
Return on Assets (ROA)
-67.58%
TTM Avg
-90.98%
3Y Avg
-83.38%
5Y Avg
-70.12%
Market Cap
$16.67M
Return on Assets (ROA)
-59.70%
TTM Avg
-56.25%
3Y Avg
-61.89%
5Y Avg
-61.99%
Market Cap
$17.68M
Return on Assets (ROA)
-30.06%
TTM Avg
65.41%
3Y Avg
-56.95%
5Y Avg
-76.50%
Market Cap
$16.53M
Return on Assets (ROA)
-68.66%
TTM Avg
-45.54%
3Y Avg
-39.28%
5Y Avg
-39.25%
Market Cap
$16.50M
Return on Assets (ROA)
-116.60%
TTM Avg
-66.28%
3Y Avg
-71.56%
5Y Avg
-63.10%
Market Cap
$17.84M
Return on Assets (ROA)
-39.68%
TTM Avg
-29.52%
3Y Avg
-26.86%
5Y Avg
-20.28%
Market Cap
$17.99M
Return on Assets (ROA)
-548.74%
TTM Avg
-346.44%
3Y Avg
-242.08%
5Y Avg
-167.09%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Palatin Technologies, Inc. (PTN) | $17.14M | -98.29% | -314.03% | -259.71% | -198.18% |
| Lipocine Inc. (LPCN)vs › | $17.11M | -49.72% | -28.29% | -39.08% | -40.04% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.75M | -67.58% | -90.98% | -83.38% | -70.12% |
| Marker Therapeutics, Inc. (MRKR)vs › | $16.67M | -59.70% | -56.25% | -61.89% | -61.99% |
| PAVmed Inc. (PAVM)vs › | $17.68M | -30.06% | 65.41% | -56.95% | -76.50% |
| TScan Therapeutics, Inc. (TCRX)vs › | $16.53M | -68.66% | -45.54% | -39.28% | -39.25% |
| Dyadic International, Inc. (DYAI)vs › | $16.50M | -116.60% | -66.28% | -71.56% | -63.10% |
| Cosmos Health Inc. (COSM)vs › | $17.84M | -39.68% | -29.52% | -26.86% | -20.28% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $17.99M | -548.74% | -346.44% | -242.08% | -167.09% |
| BioCardia, Inc. (BCDA)vs › | $15.79M | -154.34% | -227.23% | -240.86% | -184.63% |
ROA
-98.3%
ROE
-125.3%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2026-06-30 | -98.29% |
| 2025-06-30 | -529.77% |
| 2024-06-30 | -276.81% |
| 2023-06-30 | -133.99% |
| 2022-06-30 | -100.35% |
| 2021-06-30 | -49.88% |
| 2020-06-30 | -26.37% |
| 2019-06-30 | 34.16% |
| 2018-06-30 | 63.31% |
| 2017-06-30 | -23.46% |
| 2016-06-30 | -467.92% |
| 2015-06-30 | -59.94% |
| 2014-06-30 | -110.90% |
| 2013-06-30 | -83.20% |
| 2012-06-30 | -320.66% |
| 2011-06-30 | -60.53% |
| 2010-06-30 | -14.47% |
| 2009-06-30 | -36.38% |
| 2008-06-30 | -75.21% |
| 2007-06-30 | -64.87% |
| 2006-06-30 | -72.31% |
| 2005-06-30 | -40.83% |
| 2004-06-30 | -107.95% |
| 2003-06-30 | -90.51% |
| 2002-06-30 | -130.59% |
| 2001-06-30 | -74.41% |
| 2000-06-30 | -92.10% |
| 1999-06-30 | -255.32% |
| 1998-06-30 | -152.31% |
| 1997-06-30 | -37.59% |
